CibasES, AliSZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid, 2017; 27:1341–1346; doi: 10.1089/thy.2017.0500
2.
HaugenBR, AlexanderEK, BibleKC, et al.2015. American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016; 26:1–133; doi: 10.1089/thy.2015.0020
3.
LeeSJ, SongCM, JiYB, et al.Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma. Langenbecks Arch Surg, 2021; 406:1223–1231; doi: 10.1007/s00423-021-02189-7
4.
SanabriaA.Experience with active surveillance of thyroid low-risk carcinoma in a developing country. Thyroid, 2020; 30:985–991; doi: 10.1089/thy.2019.0522
5.
SmuleverA, PitoiaF.Active surveillance in small cytological indeterminate thyroid nodules: A call to common sense?. Endocrine, 2021; 72:505–512; doi: 10.1007/s12020-020-02566-0
6.
ConzoG, AveniaN, AnsaldoGL, et al.Surgical treatment of thyroid follicular neoplasms: Results of a retrospective analysis of a large clinical series. Endocrine, 2017; 55:530–538; doi: 10.1007/s12020-016-0953-2
7.
RagoT, Di CoscioG, BasoloF, et al.Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: Results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) 2007; 66:13–20; doi: 10.1111/j.1365-2265.2006.02677.x
LeeSH, BaekJS, LeeJY, et al.Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm. Endocr Pathol, 2013; 24:177–183; doi: 10.1007/s12022-013-9263-x
